Shares Outstanding (Quarterly) Chart

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 79.76M
March 31, 2026 63.02M
December 31, 2025 62.95M
September 30, 2025 56.60M
June 30, 2025 56.59M
March 31, 2025 56.45M
December 31, 2024 55.15M
September 30, 2024 55.03M
June 30, 2024 55.01M
March 31, 2024 54.92M
December 31, 2023 54.91M
September 30, 2023 54.82M
June 30, 2023 54.81M
March 31, 2023 47.92M
Date Value
December 31, 2022 47.90M
September 30, 2022 47.85M
June 30, 2022 47.77M
March 31, 2022 47.70M
December 31, 2021 47.60M
September 30, 2021 47.19M
June 30, 2021 47.04M
March 31, 2021 46.79M
December 31, 2020 43.71M
September 30, 2020 43.70M
June 30, 2020 43.70M
March 31, 2020 43.70M
December 31, 2019 43.70M
September 30, 2019 43.70M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Q32 Bio, Inc. 23.74M
Intellia Therapeutics, Inc. 140.02M
Twist Bioscience Corp. 62.67M
Beam Therapeutics, Inc. 103.26M
Revolution Medicines, Inc. 214.24M